REGINA, Saskatchewan, July 02, 2024 (GLOBE NEWSWIRE) -- PROTON CAPITAL CORP. (“Proton” or the “Corporation”) (TSXV: PTN) is pleased to announce that, further to its news releases dated April 20, 2023, July 26, 2023, August 31, 2023, October 10, 2023, January 22, 2024, February 21, 2024, March 22, 2024 and May 27, 2024, the final tranche of its brokered public prospectus offering (the “Offering”) will close on July 18, 2024. The Offering is being conducted in each of the provinces of Canada, other than Quebec, by way of a long form prospectus dated May 24, 2024 (the “Prospectus”). The Prospectus is accessible on SEDAR+ at www.sedarplus.ca.
Other Information and Halt
Investors are cautioned that, except as disclosed in the Prospectus, any information released or received with respect to the Offering may not be accurate or complete and should not be relied upon. This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction. The common shares of Proton are currently halted from trading and will remain halted until after the completion of the final tranche of the Offering.
About Proton Capital Corp.
Proton was incorporated on September 1, 2021 by certificate of incorporation issued pursuant to the provisions of the Business Corporations Act (Alberta). As a Capital Pool Company, Proton completed its qualifying transaction as defined in Policy 2.4 of the TSX Venture Exchange on June 6, 2024. The qualifying transaction consisted of its strategic alliance with PharmaChoice Canada Inc. and the acquisition of 75% of the outstanding shares of Saskatoon Family Pharmacy Ltd. Proton is currently halted until after the completion of the final tranche of the Offering, and after completion of the final tranche, Proton will undergo a name change to PharmaCorp Rx Inc. and begin trading under the symbol: PCRX.
For further information, contact:
Mr. Alan Simpson
Suite #203, 303 Wellman Lane, Saskatoon, SK S7T 0J1
Tel: (306) 536-3771
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
The securities referred to in this news release have not been, and will not be, registered under the United States Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold within the United States or to, or for the account or benefit of, any U.S. person unless they are registered under the United States Securities Act of 1933, as amended, and any applicable state securities laws, or an applicable exemption from the such U.S. registration requirements is available. This news release does not constitute an offer for sale of securities, nor a solicitation for offers to buy any securities. Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the company and management, as well as financial statements.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Forward-Looking Information: This news release contains “forward-looking information” regarding the Corporation within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. In particular, this news release contains forward-looking information in relation to: the completion of the final tranche of the Offering, the date of completion of the final tranche of the Offering, the removal of the halt in respect of the trading of the common shares of the Corporation and the name change of the Corporation. This forward-looking information reflects current beliefs and is based on information currently available to the management of the Corporation and on assumptions the Corporation believes are reasonable. These assumptions include, but are not limited to: the closing of the final tranche of the Offering; and the receipt of all required approvals for the closing of the final tranche of the Offering and the resumption of the trading of the common shares of the Corporation. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Corporation to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; delay or failure to receive board of directors, third party or regulatory approvals; competition; changes in legislation, including environmental legislation, affecting the Corporation; the timing and availability of external financing on acceptable terms; conclusions of economic evaluations and appraisals; and lack of qualified, skilled labour or loss of key individuals. A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Prospectus and the Corporation’s other disclosure documents on the SEDAR+ website at www.sedarplus.ca. Although the Corporation has attempted to identify important risks and factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement. The forward-looking information contained in this news release represents the expectations of the Corporation as of the date of this news release and, accordingly, is subject to change after such date. However, the Corporation expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
